title: Impulse control disorders and compulsive behaviors associated with dopaminergic therapies in Parkinson disease.
abstract: Impulse control disorders (ICD) (most commonly pathologic gambling, hypersexuality, and uncontrollable spending) and compulsive behaviors can be triggered by dopaminergic therapies in Parkinson disease (PD). ICD are especially prevalent in patients receiving a dopamine agonist as part of their treatment regimen for PD, and have also been reported when dopamine agonists are used for other indications (e.g., restless legs syndrome). Although these iatrogenic disorders are common, affecting 1 in 7 patients with PD on dopamine agonists, they often elude detection by the treating physician. ICD lead to serious consequences, causing significant financial loss and psychosocial morbidity for many patients and families. ICD can appear at any time during treatment with dopamine agonists, sometimes within the first few months, but most often after years of treatment, particularly when patients receive dopamine agonists and levodopa together. In most cases ICD resolve if the dopamine agonist is withdrawn, and PD motor symptoms are managed with levodopa monotherapy. Familiarity with the clinical aspects, risk factors, pathophysiology, and management of ICD is essential for physicians using dopaminergic therapies to treat PD and other disorders.
authors: Parkinson Disease Program (HDW), Sinai Hospital of Baltimore; Department of Neurology (HDW), Johns Hopkins University Medical School, Baltimore, MD; Mental Health Services (LM), Michael E. DeBakey Veterans Affairs Medical Center, Houston; and Departments of Psychiatry and Neurology (LM), Baylor College of Medicine, Houston, TX.
authors: Howard D
authors: HD
authors: Weiss
authors: Laura
authors: L
authors: Marsh
references: Neurology. 2006 Oct 10;67(7):1258-61
references: 17030761
references: Mayo Clin Proc. 2009 Apr;84(4):310-6
references: 19339647
references: Mov Disord. 2009 Aug 15;24(11):1561-70
references: 19526584
references: Neurologist. 2010 Nov;16(6):406-7
references: 21150395
references: Arch Neurol. 2010 May;67(5):589-95
references: 20457959
references: Neurologist. 2008 Mar;14(2):89-99
references: 18332838
references: Mov Disord. 2008 Jan;23(1):75-80
references: 17960796
references: Mov Disord. 2009 Jul 30;24(10):1461-7
references: 19452562
references: Arch Neurol. 2007 Aug;64(8):1089-96
references: 17698698
references: Arch Neurol. 2010 Jan;67(1):58-63
references: 20065130